Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

SPDR SP BIOTECH ETF: (XBI)

(Market Close from AMEX) As of Nov 21, 2014 03:59 PM ET

 Add to portfolio

$174.04 USD

174.04
320,824

+1.47 (0.85%)

Volume: 320,824

Zacks ETF Rank: 2 - Buy [?]   2      

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 172.57
Open 175.00
Bid 174.03
Ask 174.91
Day Low-High 173.01-175.75
52wk Low-High 115.31-177.48
Volume 320,824
NAV (month end) 171.46
Premium (+)/Discount (-) (month end)+1.11

Zacks Premium Research for XBI

Zacks ETF Rank [?] Buy 2
ETF Risk [?] High
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $1.55 (0.89%)
Issuer STATE STREET GLOBAL ADVISORS

Benchmark for XBI

SP BIOTECHNOLOGY SELECT INDUSTRY INDEX

The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Fund Summary for XBI

SPDR SP BIOTECH ETF

The SPDR S&P Biotech ETF, before expenses, seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index.